Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant combined therapy with trastuzumab in patients with HER2‑ positive breast cancer and cardiac alterations: implications for optimal cardio‑oncology care.
Grela-Wojewoda A, Niemiec J, Sas-Korczyńska B, Zemełka T, Puskulluoglu M, Wysocki WM, Wojewoda T, Pacholczak-Madej R, Adamczyk A, Mucha-Małecka A, Ziobro M, Konduracka E. Grela-Wojewoda A, et al. Pol Arch Intern Med. 2022 Apr 28;132(4):16204. doi: 10.20452/pamw.16204. Epub 2022 Jan 28. Pol Arch Intern Med. 2022. PMID: 35089680 Free article.
Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population.
Grela-Wojewoda A, Püsküllüoğlu M, Sas-Korczyńska B, Zemełka T, Pacholczak-Madej R, Wysocki WM, Wojewoda T, Adamczyk A, Lompart J, Korman M, Mucha-Małecka A, Ziobro M, Konduracka E. Grela-Wojewoda A, et al. Among authors: pacholczak madej r. Cancers (Basel). 2022 Jul 10;14(14):3353. doi: 10.3390/cancers14143353. Cancers (Basel). 2022. PMID: 35884413 Free PMC article.
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.
Pacholczak-Madej R, Grela-Wojewoda A, Puskulluoglu M, Lompart J, Las-Jankowska M, Krawczak K, Wrona E, Zaręba L, Żubrowska J, Walocha J, Bazan-Socha S, Ziobro M. Pacholczak-Madej R, et al. Biomedicines. 2022 Oct 10;10(10):2528. doi: 10.3390/biomedicines10102528. Biomedicines. 2022. PMID: 36289790 Free PMC article.
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis.
Püsküllüoğlu M, Rudzińska A, Pacholczak-Madej R. Püsküllüoğlu M, et al. Among authors: pacholczak madej r. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188991. doi: 10.1016/j.bbcan.2023.188991. Epub 2023 Sep 26. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37758021 Free article. Review.
Endothelial dysfunction in patients with systemic sclerosis.
Pacholczak-Madej R, Kuszmiersz P, Bazan-Socha S, Kosałka-Wêgiel J, Iwaniec T, Zarêba L, Kielczewski S, Rams A, Walocha JA, Musiał J, Dropiñski J. Pacholczak-Madej R, et al. Postepy Dermatol Alergol. 2020 Aug;37(4):495-502. doi: 10.5114/ada.2019.83501. Epub 2020 Sep 2. Postepy Dermatol Alergol. 2020. PMID: 32994769 Free PMC article.
17 results